Politics has gotten in the way of the two sides having factual discussions concerning an assessment of Mifeprex’s safety, a consideration of pregnancy as an illness, an evaluation of maternal mortality in the U.S., and an analysis of whether Mifeprex’s availability is associated with more abortions.